Mkts

Recursion Pharmaceuticals, Inc.

NASDAQ: RXRX
$4.03-0.21 (-4.95%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
3.784.16
52-week range
2.775.84
Today
Open4.05
Previous close4.03
Volume18.82M
Valuation
Market cap2.41B
P/E ratio—
EPS (TTM)-1.04
Income & risk
Dividend / yield—
Beta1.18
Avg volume22.56M
Discussion

RXRX News

Stories mentioning RXRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue6,47235,5385,17519,22314,7454,54626,08214,417
Cost of Goods Sold12,49014,27614,68720,16121,82912,79412,0799,199
Gross Profit(6,018)21,262(9,512)(938.00)(7,084)(8,248)14,0035,218
Operating Expenses
Research & Development87,89695,939121,062128,636129,63498,33374,60073,928
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(128,505)(108,335)(172,202)(176,227)(191,368)(183,767)(98,354)(100,543)
Interest Income
Interest Expense
Other Expense
Pretax Income(122,108)(108,103)(162,250)(171,897)(202,645)(178,898)(95,675)(98,063)
Tax Provision(4,604)19.003.000.00(158.00)8.00167.00(523.00)
Net Income (Loss)(117,504)(108,122)(162,253)(171,897)(202,487)(178,906)(95,842)(97,540)
Earnings Per Share (Basic)(0.22)(0.24)(0.36)(0.41)(0.50)(0.65)(0.34)(0.40)
Earnings Per Share (Diluted)(0.22)(0.24)(0.36)(0.41)(0.50)(0.65)(0.34)(0.40)
Weighted Average Shares Outstanding (Basic)529,304447,446446,988417,361402,772274,207282,583242,196
Weighted Average Shares Outstanding (Diluted)529,304447,446446,988417,361402,772274,207282,583242,196

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RXRX

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol RXRX. It last traded at $4.03 (Oct 30, 2026, 4:00 PM ET), down 5.0% on the day. That gives Recursion Pharmaceuticals a market capitalisation of $2.4B.

Over the past 52 weeks RXRX has traded between $2.77 and $5.84.

Revenue for the quarter ended Mar 31, 2026 was $6.5M; a net loss of $117.5M. Revenue was down 56.1% from $14.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$6.5M-$117.5M-1815.6%
Dec 31, 2025$35.5M-$108.1M-304.2%
Sep 30, 2025$5.2M-$162.3M-3135.3%
Jun 30, 2025$19.2M-$171.9M-894.2%

From Recursion Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…